New Jersey is 1 of 3 states that will test a new set of metrics to assess how well new payment models have penetrated markets, explained Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute, which will lead the process in New Jersey.
New Jersey is 1 of 3 states that will test a new set of metrics to assess how well new payment models have penetrated markets, explained Linda Schwimmer, JD, president and CEO of the New Jersey Health Care Quality Institute, which will lead the process in New Jersey.
Transcript
The purpose of the Scorecard 2.0 effort is to develop a measurement tool that “reflects the reality of the market today.” How would you describe that market in New Jersey?
I would say that New Jersey has a lot of payers, meaning health plans, and hospital systems, and other physician groups that are working diligently right now to transform our healthcare system and to improve it. We could do more in that regard—we could do a better job at it. One of the ways would be having greater access to data and sharing data.
Who are your key partners in making this process a success? What will this process look like?
For the Scorecard to work, we really need to have access to data. And the health plans, as well as the State of New Jersey, are the largest holders of that data. To support his project, we’ve reached out to all those payers, and we’re going to be meeting with them to brief on the project, and to explain the benefits—both to them as well as to all New Jerseyans.
Is New Jersey’s data in good shape? Is the state positioned to provide data in a manner that will make it meaningful?
New Jersey’s data is not that transparent right now. It’s basically kept behind the walls of the purchasers and the payers. We can certainly do a better job of clearing that up, and making it more accessible, and least to those that are trying to work on making our system less of a fee-for-service (system) and more of what we call an outcomes-based system, where healthcare providers—such as physicians and hospitals working together—are paid for the outcomes they achieve from a quality and efficiency perspective. We have a long way to go to really achieving that goal, and this is the first step.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen